Press-release for stocks related to therapy for TMO

| -2.02% | O: -1.11% H: 0.0% C: 0.0%
first solution software cell therapy

Global Glioma Treatment Market Research Report 2023: Breakthrough Oncolytic Virus Therapy Offers New Hope for Glioma Patients - Forecast to 2027 and 2032
Published: 2023-11-27 (Crawled : 23:00) - prnewswire.com
TMO | News | $543.895 0.44% 830K

| 8.75% | O: -0.5% H: 0.0% C: 0.0%
KPTI | $1.255 -1.95% 620K

| 80.92% | O: 4.0% H: 1.93% C: -7.72%
AMGN | $267.41 1.77% 1.4M

| 0.25% | O: 0.03% H: 0.85% C: 0.44%
report hope treatment research global virus therapy market

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Boehringer Ingelheim to Select Patients with NSCLC for Targeted Therapy Treatment
Published: 2023-10-19 (Crawled : 13:30) - biospace.com/
TMO | News | $543.895 0.44% 830K

| 10.89% | O: -2.02% H: 0.0% C: 0.0%
diagnostic treatment companion agreement therapy

Thermo Fisher Scientific Helps Accelerate Cell Therapy Manufacturing with a Next-Generation Platform of Gibco™ CTS™ Detachable Dynabeads™
Published: 2023-09-06 (Crawled : 22:00) - biospace.com/
TMO | News | $543.895 0.44% 830K

| -4.54% | O: -2.61% H: 0.0% C: 0.0%
cell therapy platform

Global Viral & Non-Viral Vector Manufacturing Market 2023 to 2027: Growing Prominence of Gene and Cell Therapy Products Fuels the Sector
Published: 2023-07-03 (Crawled : 22:00) - prnewswire.com
LZAGY | $55.65 32K

| Email alert Add to watchlist
CTLT | $55.82 0.04% 740K

| Email alert Add to watchlist
TMO | News | $543.895 0.44% 830K

| Email alert Add to watchlist
DHR | $235.0 -0.58% 1.1M

| Email alert Add to watchlist
LZAGF | $563.5 6

| Email alert Add to watchlist
cell global growing therapy market

Global Cell & Gene Therapy Manufacturing Services Market Report 2023: Major Players Include Thermo Fisher Scientific, Merck, Charles River Laboratories International and Lonza
Published: 2023-06-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $563.5 6

| -10.43% | O: 0.45% H: 1.36% C: 1.36%
NINOY | $9.56 1.3K

Manufacturing

| -17.48% | O: 4.31% H: 0.0% C: -1.7%
LZAGY | $55.65 32K

| -8.28% | O: 2.0% H: 0.0% C: -0.97%
TMO | News | $543.895 0.44% 830K

| 1.32% | O: 0.34% H: 0.04% C: -1.46%
BLUE | $0.9729 2.09% 6.5M

| -74.39% | O: 1.62% H: 7.03% C: 2.39%
services report international cell global therapy market

Global Cell and Gene Therapy Biomanufacturing Markets Report 2022-2023 & 2031: Burgeoning Opportunities with a Robust Clinical Pipeline and Integration of Automation
Published: 2023-04-19 (Crawled : 15:00) - prnewswire.com
LZAGF | $563.5 6

| -13.21% | O: 1.28% H: 0.01% C: -1.16%
LZAGY | $55.65 32K

| -12.48% | O: -1.78% H: 0.74% C: 0.67%
TMO | News | $543.895 0.44% 830K

| -8.87% | O: -1.55% H: 0.86% C: 0.72%
GE | $149.17 -2.47% 6.2M

Electronic Technology

| 58.09% | O: 0.11% H: 0.74% C: 0.46%
DHR | $235.0 -0.58% 1.1M

| -6.17% | O: -0.64% H: 0.44% C: 0.1%
BIO | News | $277.33 -1.31% 110K

| -43.07% | O: -0.57% H: 2.71% C: 2.09%
BDX | $234.09 0.4% 620K

| -8.9% | O: 0.39% H: 1.75% C: 1.68%
TECH | $62.51 0.48% 350K

| -25.61% | O: -0.33% H: 1.39% C: 1.11%
integration report pipeline cell global therapy

Increasing Investments and Fundings in Cell and Gene Therapy Fuelling the Growth of Cell and Gene Therapy Biomanufacturing, Suggests BIS Research Study
Published: 2023-03-24 (Crawled : 16:00) - prnewswire.com
LZAGF | $563.5 6

| -5.01% | O: -1.95% H: 0.8% C: -0.28%
LZAGY | $55.65 32K

| -1.27% | O: -0.34% H: 0.0% C: -0.03%
TMO | News | $543.895 0.44% 830K

| -4.0% | O: -1.2% H: 1.85% C: 1.78%
GE | $149.17 -2.47% 6.2M

Electronic Technology

| 69.96% | O: -1.11% H: 1.97% C: 0.88%
DHR | $235.0 -0.58% 1.1M

| -2.67% | O: -0.73% H: 1.32% C: 1.24%
BIO | News | $277.33 -1.31% 110K

| -40.22% | O: -0.78% H: 1.8% C: 1.77%
BDX | $234.09 0.4% 620K

| -2.27% | O: 0.19% H: 1.66% C: 1.55%
TECH | $62.51 0.48% 350K

| -12.78% | O: -0.46% H: 1.79% C: 1.33%
investments cell research therapy growth study

Market Forecasts for Immuno-Oncology Diagnostics 2023: Sector Represents a Revolution in Cancer Therapy
Published: 2023-01-20 (Crawled : 22:00) - prnewswire.com
ABT | News | $106.76 1.42% 3.8M

| Email alert Add to watchlist
ANPCY | $1.98 338.38% 930

Manufacturing

| Email alert Add to watchlist
BIO | News | $277.33 -1.31% 110K

| Email alert Add to watchlist
TXG | $27.87 -3.73% 1.2M

| Email alert Add to watchlist
NVTA | $0.019 0.0% 22M

Health Services

| Email alert Add to watchlist
TMO | News | $543.895 0.44% 830K

| Email alert Add to watchlist
BDX | $234.09 0.4% 620K

| Email alert Add to watchlist
ANPCF | $0.148 641.22% 5K

| Email alert Add to watchlist
CSTL | $19.105 -0.5% 44K

| Email alert Add to watchlist
ICLR | $288.325 -1.2% 170K

| Email alert Add to watchlist
BIOC | $0.4349 -10.32% 750K

Health Services

| Email alert Add to watchlist
NH | $1.35 -46.64% -1.48% 0

Technology Services

| Email alert Add to watchlist
MLAB | $100.805 1.19% 8.7K

| Email alert Add to watchlist
diagnostics therapy cancer market

Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 510

| 13.48% | O: 1.12% H: 0.0% C: -1.68%
SNYNF | News | $92.7 600K

| -7.09% | O: -2.5% H: 0.0% C: 0.0%
AZNCF | $138.24 800

| -5.79% | O: -1.16% H: 1.62% C: -0.54%
NVSEF | $93.6375 6.88% 82K

| 22.87% | O: 0.05% H: 0.0% C: 0.0%
VTRS | $11.21 0.81% 2.4M

| -6.08% | O: -0.17% H: 0.25% C: -2.96%
TMO | News | $543.895 0.44% 830K

| -9.33% | O: 0.56% H: 0.97% C: -1.87%
NVO | $122.69 -0.05% 3.8M

| -10.4% | O: 0.57% H: 0.84% C: -0.01%
NVS | $94.285 1.85% 1.6M

| 0.76% | O: 0.93% H: 0.01% C: -1.16%
JNJ | News | $147.17 0.98% 3.2M

| -15.9% | O: -0.41% H: 0.2% C: -1.1%
GSK | $39.585 0.8% 1.1M

| 11.36% | O: -0.03% H: 0.17% C: -1.01%
LLY | $727.48 -2.48% 2M

| 109.86% | O: -0.4% H: 0.75% C: -1.21%
ABT | News | $106.76 1.42% 3.8M

| -6.16% | O: -0.16% H: 0.33% C: -1.5%
SNY | News | $46.545 2.55% 2.3M

| -8.67% | O: -0.14% H: 0.0% C: 0.0%
BIIB | $192.68 1.13% 590K

| -32.61% | O: 0.34% H: 0.46% C: -2.45%
AZN | $68.41 0.07% 2.9M

| -3.5% | O: 1.36% H: 0.33% C: -1.13%
AMGN | $267.41 1.77% 1.4M

| -1.66% | O: 0.0% H: 0.41% C: -1.87%
therapy growth

FDA Grants De Novo Classification to HLA Typing Test for Use as a Companion Diagnostic with a T Cell Receptor Therapy for Metastatic or Unresectable Uveal Melanoma
Published: 2022-12-07 (Crawled : 14:00) - biospace.com/
TMO | News | $543.895 0.44% 830K

| -4.12% | O: -0.58% H: 0.0% C: 0.0%
fda melanoma test diagnostic grants therapy

Thermo Fisher Scientific Introduces All-in-One AAV Production System for Scalable Gene Therapy Workflows and Commercial Applications
Published: 2022-11-16 (Crawled : 14:00) - biospace.com/
TMO | News | $543.895 0.44% 830K

| -1.83% | O: 0.71% H: 0.0% C: 0.0%
system commercial therapy

Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers
Published: 2022-09-27 (Crawled : 23:00) - biospace.com/
TMO | News | $543.895 0.44% 830K

| 3.63% | O: 0.65% H: 0.0% C: 0.0%
fda thyroid test diagnostic approval therapy

Stem Cell Therapy Global Market Report 2022: Rising Research and Development Spending, and Increasing Healthcare Expenditure Present Future Opportunities
Published: 2022-08-10 (Crawled : 16:00) - prnewswire.com
TMO | News | $543.895 0.44% 830K

| -8.81% | O: 0.8% H: 0.61% C: 0.54%
research global report therapy market

Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
Published: 2022-06-06 (Crawled : 13:20) - biospace.com/
TMO | News | $543.895 0.44% 830K

| -5.16% | O: -0.14% H: 0.0% C: 0.0%
research solutions vaccine therapy

Thermo Fisher Scientific Introduces New Cell and Gene Therapy Integrated Commercial Packaging and Distribution Services
Published: 2022-02-15 (Crawled : 16:00) - biospace.com/
TMO | News | $543.895 0.44% 830K

| -5.02% | O: 1.12% H: 0.66% C: -1.9%
gene therapy distribution cel services therapy commercialization

Worldwide Pharmaceutical Contract Development & Manufacturing Industry to 2026 - Growing Need for Cell and Gene Therapies Presents Opportunities
Published: 2021-12-14 (Crawled : 11:00) - prnewswire.com
LZAGF | $563.5 6

| -31.99% | O: -2.62% H: 0.0% C: 0.0%
LZAGY | $55.65 32K

| -28.77% | O: -1.64% H: 0.19% C: -0.71%
TMO | News | $543.895 0.44% 830K

| -16.91% | O: -0.2% H: 0.0% C: 0.0%
DHR | $235.0 -0.58% 1.1M

| -24.54% | O: -0.84% H: 0.0% C: 0.0%
CTLT | $55.82 0.04% 740K

| -54.61% | O: 0.26% H: 0.44% C: -0.68%
contract cel gene therapies growing gene therapy therapy

FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $543.895 0.44% 830K

| -12.95% | O: 0.44% H: 2.01% C: 0.82%
TAK | News | $13.19 0.23% 740K

| -4.85% | O: 2.03% H: 3.33% C: 0.07%
RGNX | $15.49 -3.85% 210K

| -51.65% | O: 0.91% H: 2.93% C: 2.79%
BIIB | $192.68 1.13% 590K

| -24.93% | O: 0.19% H: 2.32% C: 1.7%
disease fda gene therapies therapy gene therapy rare

Outlook on the Regenerative Medicine Global Market to 2026 - Focus on Stem Cell Therapy, Biomaterial and Tissue Engineering Among Others
Published: 2021-10-18 (Crawled : 22:00) - prnewswire.com
TMO | News | $543.895 0.44% 830K

| -9.36% | O: 0.51% H: 1.02% C: 0.19%
NVS | $94.285 1.85% 1.6M

| 13.04% | O: 1.0% H: 0.23% C: -0.01%
MDT | $79.255 0.08% 2.6M

| -34.49% | O: 0.82% H: 0.87% C: 0.4%
BDX | $234.09 0.4% 620K

| -3.12% | O: 0.44% H: 1.44% C: 1.35%
BAX | $39.47 -0.45% 1.3M

| -49.22% | O: 0.33% H: 1.64% C: 1.58%
ABBV | News | $165.97 0.8% 3.1M

| 53.74% | O: 0.3% H: 0.29% C: -0.28%
IART | News | $29.12 -7.94% 970K

| -53.25% | O: 0.62% H: 1.84% C: 0.9%
AMGN | $267.41 1.77% 1.4M

| 30.43% | O: 0.67% H: 1.18% C: 1.12%
stem cell therapy

New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies
Published: 2021-10-05 (Crawled : 15:00) - biospace.com/
TMO | News | $543.895 0.44% 830K

| -6.33% | O: 0.36% H: 1.91% C: 0.15%
gene therapies expansion therapy gene therapy

← Previous
1
2
Next →

Gainers vs Losers

71%

29%

Top 10 Gainers

AGBA | News | $1.27 217.5% 120M

Finance

EGOX | $0.0503 39.72% 320M

RWOD | $10.52 31.56% 5.9M

ZCMD | $1.905 31.38% 30M

Commercial Services

MRDB 4 | $0.536 27.65% 2M

BSFC | $0.0822 27.64% 75M

Manufacturing

TPET | $0.4121 25.68% 45M

NVFY | $2.65 25.59% 33M

Consumer Durables

INDO | $5.1 25.0% 15M

Energy Minerals

CHRO | $1.53 24.9% 100K